Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Hedge Funds

13G Filing: Park West Asset Management and Eagle Pharmaceuticals Inc. (EGRX)

Published on August 25, 2017 at 3:38 pm by Insider Monkey Staff in Hedge Funds
<< Prev
Page 5 of 8
Next >>
See All

Page 5 of 8 – SEC Filing

Item 3.  If This Statement Is Filed Pursuant to Rules 13d-1(b) or 13d-2(b) or (c), Check Whether the Person Filing is a:
Not Applicable.
Item 4.  Ownership:
As reported in the cover pages to this report, the ownership information with respect to each of PWAM and Mr.
Park is as follows:
(a)     Amount Beneficially Owned: 786,420*
(b)    Percent of Class: 5.2%*
(c)     Number
of Shares as to which the person has:
(i)     Sole power to vote or to direct the vote: 786,420*
(ii)     Shared power to vote or to direct the vote: 0  
(iii)     Sole power to dispose or to direct the disposition of: 786,420*
(iv)     Shared power to dispose or to direct the disposition of: 0  

* This Schedule 13G is being jointly filed by (i) PWAM, a Delaware limited liability company and the investment
manager to (a) PWIMF, a Cayman Islands exempted company that is the holder of 697,739 shares of Common Stock, as reported on this
Schedule 13G, and (b) PWPI, a Cayman Islands exempted company that is the holder of 88,681 shares of Common Stock, as reported
on this Schedule 13G; and (ii) Mr. Park, as the sole member and manager of PWAM.

The 786,420 shares of Common Stock held in the aggregate by the PW Funds, which constitute approximately 5.2%
of the shares of Common Stock deemed to be outstanding as of August 14, 2017, may be deemed to be beneficially owned (x) indirectly
by PWAM, as the investment adviser to PWIMF and PWPI, and (y) indirectly by Mr. Park, as the sole member and manager of PWAM. The
foregoing beneficial ownership percentage is based upon 15,169,241 shares of Common Stock issued and outstanding as of August 2,
2017, based on information reported by the Company in its Quarterly Report on Form 10-Q filed with the Securities and Exchange
Commission on August 9, 2017.

Item 5.  Ownership of Five Percent or Less of a Class:
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased
to be the beneficial owner of more than five percent of the class of securities, check the following: [   ]
Item 6.  Ownership of More Than Five Percent on Behalf of Another Person:
Not Applicable.
Item 7.  Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:
Not Applicable.
Item 8.  Identification and Classification of Members of the Group:
Not Applicable.
Item 9.  Notice of Dissolution of Group:
Not Applicable.
Item 10.  Certification:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above
were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of
the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose
or effect.

Follow Eagle Pharmaceuticals Inc. (NASDAQ:EGRX)
<< Prev
Page 5 of 8
Next >>
See All

Related Insider Monkey Articles
13G Filing: Rima Senvest Management and Medigus Ltd. (MDGS)13G Filing: Sabby Capital and CEL-SCI Corporation (CVM)
13G Filing: EcoR1 Capital and Kura Oncology Inc (KURA)13G Filing: Bulldog Investors and MVC Capital Inc. (MVC)
13G Filing: Point72 Asset Management and Pacira Pharmaceuticals Inc. (PCRX)13G Filing: Park West Asset Management and Internap Corp (INAP)